Editorial: Small molecules and biologics for future purinergic therapeutics.

导出 OA

翻译打印收藏纠错

第一作者： Kenneth A,Jacobson

第一单位： Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, 20892, USA. kennethj@niddk.nih.gov.

作者： Kenneth A,Jacobson ^[1] ; Daniela,Salvemini ^[2]

作者单位： Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, 20892, USA. kennethj@niddk.nih.gov. ^[1] Department of Pharmacology and Physiology and the Henry and Amelia Nasrallah Center for Neuroscience, Saint Louis University School of Medicine, 1402 South Grand Blvd, St. Louis, MO, 63104, USA. daniela.salvemini@health.slu.edu. ^[2]

关键词 ATP Adenosine Drug discovery G protein-coupled purinergic receptors Ligand-gated P2X receptors channels Purinergic signalling

主题词受体, 嘌呤能P2X(Receptors, Purinergic P2X);生物制品(Biological Products);信号传导(Signal Transduction)

DOI 10.1007/s11302-023-09964-9

PMID 37676356

发布时间 2024-03-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交